EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomarkers for Lung Nodule Risk Stratification: Are We There Yet?

Sushan Gupta, Swati Jain iD, Krupa Shingada, Aikta Rajput, Jonathan S Kurman iD

Diagnostics · 16.06.2026 · 16 (12) · 1861

DOI: 10.3390/diagnostics16121861 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 16.06.2026. Verfasst von Sushan Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary & Critical Care, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The number of pulmonary nodules detected is steadily increasing. While some are low or high risk, most are indeterminate. Within the indeterminate group, the vast majority are benign. Statification of indeterminate pulmonary nodules (IPNs) is challenging. Validated risk calculators are not routinely employed in clinical practice because they are cumbersome. Most clinicians rely upon clinical gestalt. This strategy often results in unnecessary biopsies, which are costly, stressful, and have the potential for iatrogenic injury. There are a number of commercially available lung cancer risk biomarkers, which each have their own strengths and weaknesses. Barriers to widespread adoption include lack of guideline support, clinical practice inertia, and limited clinical utility data. Upcoming multicenter trials aim to provide high quality data that could lead to guideline incorporation.

Schlagwörter

Stichwörter der Autor:innen

biomarkerlung nodulespulmonary nodulesrisk stratification

Autor:innen und Institutionen

  • Department of Pulmonary & Critical Care, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Northwell Health, New York, NY 11042, USA.

ORCID-Profile: Swati Jain, Jonathan S Kurman

Zitieren

APA

Gupta, S., Jain, S., Shingada, K., Rajput, A., & Kurman, J. S. (2026). Biomarkers for Lung Nodule Risk Stratification: Are We There Yet?. Diagnostics, 16(12), 1861. https://doi.org/10.3390/diagnostics16121861

Vancouver

Gupta S, Jain S, Shingada K, Rajput A, Kurman JS. Biomarkers for Lung Nodule Risk Stratification: Are We There Yet?. Diagnostics. 2026;16(12):1861. doi:10.3390/diagnostics16121861

BibTeX
@article{Gupta2026,
  author = {Gupta, Sushan and Jain, Swati and Shingada, Krupa and Rajput, Aikta and Kurman, Jonathan S},
  title = {Biomarkers for Lung Nodule Risk Stratification: Are We There Yet?},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {12},
  pages = {1861},
  doi = {10.3390/diagnostics16121861}
}
Kostenlos starten →